Recommended Liver Function Monitoring for Tigecycline
Patients on tigecycline, an antibiotic used for complicated infections, need liver function tests (LFTs) monitored due to risks of elevated transaminases and rare hepatotoxicity. Baseline LFTs are required before starting treatment.[1]
During therapy, check LFTs weekly in patients without liver impairment. For those with moderate to severe hepatic impairment, monitor more frequently, such as every 3-5 days, adjusting based on clinical response and trends.[1][2]
Why Weekly Monitoring During Treatment?
Tigecycline can cause asymptomatic transaminase elevations in up to 10-15% of patients, peaking within the first 1-2 weeks. Weekly checks catch this early, as levels often normalize after discontinuation. Guidelines from the FDA label and infectious disease experts emphasize this to balance efficacy against liver risks.[1][3]
Adjustments for Liver Impairment or Risk Factors
- Child-Pugh B/C impairment: Reduce dose (e.g., 25 mg IV every 12 hours after loading) and monitor LFTs every 72 hours or sooner if symptoms like jaundice appear.
- High-risk patients (e.g., alcohol use, concomitant hepatotoxins): Baseline plus twice-weekly monitoring.
No routine monitoring needed post-treatment unless abnormalities persist.[1][2]
What Do Abnormal Results Mean?
Mild elevations (up to 3x upper limit) often resolve without stopping therapy. Levels >5x prompt discontinuation. Symptoms like nausea or fatigue warrant immediate recheck—contact providers promptly.[1][4]
Comparison to Similar Antibiotics
Unlike vancomycin (daily renal checks, less liver focus), tigecycline prioritizes hepatic monitoring over renal. Linezolid requires weekly LFTs too, but tigecycline's risk profile drives stricter adherence.[3]
[1]: Tigecycline FDA Label
[2]: IDSA Guidelines on Complicated Infections
[3]: UpToDate: Tigecycline Overview
[4]: Drugs.com: Tigecycline Side Effects